Frequency 发表于 2025-3-25 07:06:24

http://reply.papertrans.cn/1/39/3845/3845-21.png

钱财 发表于 2025-3-25 09:13:20

http://reply.papertrans.cn/1/39/3845/3845-22.png

KEGEL 发表于 2025-3-25 15:36:38

Submitted on: 29 June 2010.
Revised on: 03 September 2010.
Accepted on: 27 October 2010.

___________________Blood and Lymphatic Cancer-Targets and Therapy

发誓放弃 发表于 2025-3-25 19:45:30

Submitted on: 29 September 2018.
Revised on: 01 January 2019.
Accepted on: 28 February 2019.

___________________Blood and Lymphatic Cancer-Targets and Therapy

笨拙的你 发表于 2025-3-25 22:52:15

Submitted on: 21 March 2008.
Revised on: 06 June 2008.
Accepted on: 11 July 2008.

___________________Blood and Lymphatic Cancer-Targets and Therapy

harrow 发表于 2025-3-26 03:58:51

Submitted on: 26 February 2019.
Revised on: 03 May 2019.
Accepted on: 03 June 2019.

___________________Blood and Lymphatic Cancer-Targets and Therapy

灰姑娘 发表于 2025-3-26 04:35:42

http://reply.papertrans.cn/1/39/3845/3845-27.png

RALES 发表于 2025-3-26 08:58:06

http://reply.papertrans.cn/1/39/3845/3845-28.png

chemoprevention 发表于 2025-3-26 14:37:06

http://reply.papertrans.cn/1/39/3845/3845-29.png

Hyperplasia 发表于 2025-3-26 17:09:13

Submitted on: 14 July 2010.
Revised on: 15 August 2010.
Accepted on: 04 September 2010.

___________________Blood and Lymphatic Cancer-Targets and Therapy
页: 1 2 [3] 4
查看完整版本: ESCI期刊Blood and Lymphatic Cancer-Targets and Therapy 2024/2025影响因子:3.943 (BLOOD LYMPHAT CANCER) (1179-9889). (ONCOLOGY)